ClearPoint Neuro (CLPT) Accounts Payables (2011 - 2026)

ClearPoint Neuro has disclosed Accounts Payables across 16 years of filings, most recently posting $2.3 million for Q1 2026.

• Accounts Payables for Q1 2026 came in at $2.3 million, up 91.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.3 million (up 91.61% YoY), and the FY2025 annual result was $1.3 million, down 6.27% from the prior year.
• Accounts Payables came in at $2.3 million for Q1 2026 at ClearPoint Neuro, up from $1.3 million in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $2.3 million in Q1 2026 to a low of $272000.0 in Q4 2022.
• The 5-year median for Accounts Payables is $1.2 million (2025), against an average of $1.1 million.
• Across the five-year window, Accounts Payables slumped 43.11% in 2023 and surged 240.97% in 2024, its largest moves.
• ClearPoint Neuro's Accounts Payables stood at $272000.0 in 2022, then jumped by 44.49% to $393000.0 in 2023, then soared by 240.97% to $1.3 million in 2024, then fell by 6.27% to $1.3 million in 2025, then surged by 85.51% to $2.3 million in 2026.
• The last three Accounts Payables figures came in at $2.3 million (Q1 2026), $1.3 million (Q4 2025), and $723000.0 (Q3 2025), per Business Quant data.